We evaluated the effect of the application of cryo-preserved amniotic membrane on the healing of 26 non-healing wounds (18 patients) with varying aetiologies and baseline sizes (average of 15.4 cm2 ), which had resisted the standard of care treatment for 6 to 456 weeks (average 88.8 weeks). Based on their average general responses to the application of cryo-preserved AM, we could differentiate three wound groups. The first healed group was characterised by complete healing (100% wound closure, maximum treatment period 38 weeks) and represented 62% of treated wounds. The wound area reduction of at least 50% was reached for all wounds in this group within the first 10 weeks of treatment. Exactly 19% of the studied wounds responded partially to the treatment (partially healed group), reaching less than 25% of closure in the first 10 weeks and 90% at maximum for extended treatment period (up to 78 weeks). The remaining 19% of treated wounds did not show any reaction to the AM application (unhealed defects). The three groups have different profiles of wound area reduction, which can be used as a guideline in predicting the healing prognosis of non-healing wounds treated with a cryo-preserved amniotic membrane.

2nd Department of Surgery Department of Cardiovascular Surgery 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Clinic of Dermatovenerology General Teaching Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Cardiovascular Surgery Motol University Hospital Prague Czech Republic

Department of Transplantation and Tissue Bank Motol University Hospital Prague Czech Republic

Department of Vascular Surgery Na Homolce Hospital Prague Czech Republic

Laboratory of the Biology and Pathology of the Eye Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol. 2015;173(2):370‐378. PubMed PMC

Zelen CM, Serena TE, Denoziere G, Fetterolf DE. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013;10(5):502‐507. PubMed PMC

Moore Z. Why is EWMA interested in implementation?. (Oral presentation). 20th Conference of the European Wound Management Association, Geneva, 2010. Frederiksberg, Denmark: EWMA; 2010.

Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care (New Rochelle). 2015;4(9):560‐582. PubMed PMC

Jarbrink K, Ni G, Sonnergren H, et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Syst Rev. 2017;6(1):15. PubMed PMC

Gibbons GW. Grafix([R]), a cryopreserved placental membrane, for the treatment of chronic/stalled wounds. Adv Wound Care (New Rochelle). 2015;4(9):534‐544. PubMed PMC

Johnson A, Gyurdieva A, Dhall S, Danilkovitch A, Duan‐Arnold Y. Understanding the impact of preservation methods on the integrity and functionality of placental allografts. Ann Plast Surg. 2017;79(2):203‐213. PubMed

Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111‐121. PubMed PMC

Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells. 2008;26(2):300‐311. PubMed

Pathak M, Olstad OK, Drolsum L, et al. The effect of culture medium and carrier on explant culture of human limbal epithelium: a comparison of ultrastructure, keratin profile and gene expression. Exp Eye Res. 2016;153:122‐132. PubMed

Barr SM. Dehydrated amniotic membrane allograft for treatment of chronic leg ulcers in patients with multiple comorbidities: a case series. J Am Coll Clin Wound Spec. 2014;6(3):38‐45. PubMed PMC

Jirsova K, Jones GLA. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting—a review. Cell Tissue Bank. 2017;18(2):193‐204. PubMed

Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res. 2012;349(2):447‐458. PubMed

Dua HS, Azuara‐Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83(6):748‐752. PubMed PMC

Litwiniuk M, Bikowska B, Niderla‐Bielinska J, et al. Potential role of metalloproteinase inhibitors from radiationsterilized amnion dressings in the healing of venous leg ulcers. Mol Med Rep. 2012;6(4):723‐728. PubMed

McQuilling JP, Vines JB, Kimmerling KA, Mowry KC. Proteomic comparison of amnion and Chorion and evaluation of the effects of processing on placental membranes. Wounds. 2017;29(6):E36‐E40. PubMed PMC

Bennett JP, Matthews R, Faulk WP. Treatment of chronic ulceration of the legs with human amnion. Lancet. 1980;1(8179):1153‐1156. PubMed

Ananian CE, Davis RD, Johnson EL, et al. Wound closure outcomes suggest clinical equivalency between lyopreserved and cryopreserved placental membranes containing viable cells. Adv Wound Care (New Rochelle). 2019;8(11):546‐554. PubMed PMC

Zelen CM, Serena TE, Snyder RJ. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers. Int Wound J. 2014;11(2):122‐128. PubMed PMC

Suzuki K, Michael G, Tamire Y. Viable intact cryopreserved human placental membrane for a non‐surgical approach to closure in complex wounds. J Wound Care. 2016;25(Sup10):S25‐S31. PubMed

Regulski M, Jacobstein DA, Petranto RD, Migliori VJ, Nair G, Pfeiffer D. A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds. Ostomy Wound Manage. 2013;59(12):38‐43. PubMed

Bianchi C, Cazzell S, Vayser D, et al. A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix([R])) allograft for the treatment of venous leg ulcers. Int Wound J. 2018;15(1):114‐122. PubMed PMC

Mermet I, Pottier N, Sainthillier JM, et al. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen. 2007;15(4):459‐464. PubMed

Valiente MR, Nicolas FJ, Garcia‐Hernandez AM, et al. Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series. J Wound Care. 2018;27(12):806‐815. PubMed

Serena TE, Yaakov R, DiMarco D, et al. Dehydrated human amnion/chorion membrane treatment of venous leg ulcers: correlation between 4‐week and 24‐week outcomes. J Wound Care. 2015;24(11):530‐534. PubMed

Snyder D, Sullivan N, Margolis D, Schoelles K. Skin substitutes for treating chronic wounds. Technology Assessment Program—Technical Brief 2020;Project ID: WNDT0818.

Duan‐Arnold Y, Gyurdieva A, Johnson A, Jacobstein DA, Danilkovitch A. Soluble factors released by endogenous viable cells enhance the antioxidant and chemoattractive activities of cryopreserved amniotic membrane. Adv Wound Care (New Rochelle). 2015;4(6):329‐338. PubMed PMC

Duan‐Arnold Y, Gyurdieva A, Johnson A, Uveges TE, Jacobstein DA, Danilkovitch A. Retention of endogenous viable cells enhances the anti‐inflammatory activity of cryopreserved amnion. Adv Wound Care (New Rochelle). 2015;4(9):523‐533. PubMed PMC

Duan‐Arnold Y, Uveges TE, Gyurdieva A, Johnson A, Danilkovitch A. Angiogenic potential of cryopreserved amniotic membrane is enhanced through retention of all tissue components in their native state. Adv Wound Care (New Rochelle). 2015;4(9):513‐522. PubMed PMC

Dhall S, Sathyamoorthy M, Kuang JQ, et al. Properties of viable lyopreserved amnion are equivalent to viable cryopreserved amnion with the convenience of ambient storage. PLoS One. 2018;13(10):e0204060. PubMed PMC

Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix([R]) for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trial. Int Wound J. 2014;11(5):554‐560. PubMed PMC

Raspovic KM, Wukich DK, Naiman DQ, et al. Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting. Wound Repair Regen. 2018;26(2):213‐220. PubMed

Farivar BS, Toursavadkohi S, Monahan TS, et al. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2019;7(2):228‐233. PubMed

Ananian CE, Dhillon YS, Van Gils CC, et al. A multicenter, randomized, single‐blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast‐derived dermal substitute for the treatment of chronic diabetic foot ulcers. Wound Repair Regen. 2018;26(3):274‐283. PubMed

Johnson EL, Saunders M, Thote T, Danilkovitch A. Cryopreserved placental membranes containing viable cells result in high closure rate of nonhealing upper and lower extremity wounds of non‐diabetic and non‐venous pathophysiology. Wounds. 2021;33(2):34‐40. PubMed

Abdo RJ. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series. J Wound Care. 2016;25(Sup7):S4‐S9. PubMed

Dehghani M, Azarpira N, Mohammad Karimi V, Mossayebi H, Esfandiari E. Grafting with cryopreserved amniotic membrane versus conservative wound care in treatment of pressure ulcers: a randomized clinical trial. Bull Emerg Trauma. 2017;5(4):249‐258. PubMed PMC

Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4‐week period is a robust predictor of complete healing in a 12‐week prospective trial. Diabetes Care. 2003;26(6):1879‐1882. PubMed

Kantor J, Margolis DJ. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol. 2000;142(5):960‐964. PubMed

Kimmel HM, Robin AL. An evidence‐based algorithm for treating venous leg ulcers utilizing the Cochrane database of systematic reviews. Wounds. 2013;25(9):242‐250. PubMed

Cryopreserved amniotic membrane in chronic nonhealing wounds: a series of case reports

Inter-placental variability is not a major factor affecting the healing efficiency of amniotic membrane when used for treating chronic non-healing wounds

Outcome of Application of Cryopreserved Amniotic Membrane Grafts in the Treatment of Chronic Nonhealing Wounds of Different Origins in Polymorbid Patients: A Prospective Multicenter Study

Quantification of Analgesic and Anti-Inflammatory Lipid Mediators in Long-Term Cryopreserved and Freeze-Dried Preserved Human Amniotic Membrane